A review of nevus-associated melanoma: What is the evidence?

J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1927-1936. doi: 10.1111/jdv.18453. Epub 2022 Aug 16.

Abstract

Cutaneous melanoma may have an adjacent nevus remnant on histological examination in 30% of cases (nevus-associated melanoma, NAM), while it may appear de novo, without a precursor lesion, in the remaining 70% of cases. Nevus-associated melanoma and the concept of acquired melanocytic nevi serving as precursors of melanoma has long been considered as a controversial topic. This controversy is, in part, due to their overall low rate of transformation to melanoma and scarce data on the natural history of progression. Another matter of debate regarded the possibility that the reported differences in NAM vs. de novo melanoma were due to an underestimation of NAM in thicker lesions due to obliteration of the nevus component by the tumour. During the last few years, several evidence has accumulated in order to address these controversies. In this review, we present a comprehensive synthesis of the epidemiological, clinical, dermoscopic and genetic findings in NAM, including thin NAM, compared to de novo melanoma. Answering the questions on nevus-associated melanoma may provide further insight into the classification of these tumours and disentangle their biology and route of development from that of de novo melanoma.

Publication types

  • Review

MeSH terms

  • Humans
  • Melanoma* / diagnosis
  • Melanoma, Cutaneous Malignant
  • Nevus* / complications
  • Nevus* / epidemiology
  • Nevus* / pathology
  • Nevus, Pigmented* / complications
  • Nevus, Pigmented* / diagnosis
  • Nevus, Pigmented* / epidemiology
  • Skin Neoplasms* / diagnosis
  • Syndrome